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A B S T R A C T
Objectives: This study seeks to evaluate the incidence rate of heterotopic ossification (HO) formation in patients
afflicted by an isolated limb fracture (ILF) and a concomitant mild traumatic brain injury (mTBI).
Methods: The current study is an observational study including ILF patients with or without a concomitant mTBI
recruited from an orthopedic clinic of a Level 1 Trauma Hospital. Patients were diagnosed with a mTBI according
to the American Congress of Rehabilitation Medicine (ACRM) criteria. Radiographs taken on average 3months
post-trauma were analyzed separately by two distinct specialists for the presence of HO proximally to the
fracture site (joints or extra joints). Both raters referred to Brooker's and Della's Valle's classification to establish
signs of HO. First, analyses were conducted for the full sample. Secondly, a matched cohort was used in order to
control for specific factors, namely age, sex, type of injury, and time elapsed between the accident and the
analyzed radiograph.
Results: The full sample included a total of 183 patients with an ILF (94 females; 47.5 years old), of which 50 had
a concomitant mTBI and 133 without. Radiographic evidence of HO was significantly higher in patients with an
ILF and a mTBI compared to ILF patients (X2= 6.50; p=0.01). The matched cohort consisted of 94 participants
(i.e.; 47 patients from the ILF+mTBI group and 47 patients from the ILF group). Again, ILF+mTBI patients
presented significantly higher rates of HO signs in comparison to ILF patients (X2=3.69; p=0.04). Presence of
HO was associated with prolonged delays to return to work (RTW) only in ILF+mTBI patients (F= 4.055;
p=0.05) but not in ILF patients (F= 0.823; p=0.37).
Conclusions: Study findings suggest that rates of HO are significantly higher proximally to fracture sites when ILF
patients sustain a concomitant mTBI, even after controlling for factors known to influence HO. Moreover, results
show that HO is associated with a prolonged RTW only in ILF patients with a concomitant mTBI but not in ILF-
only patients. The impact of mTBI on HO formation warrants further attention to detect early signs of HO, to
identify shared physiopathological mechanisms and, ultimately, to design targeted therapies.
1. Introduction
Heterotopic ossification (HO), defined as an abnormal bone for-
mation occurring in extra-skeletal tissues, is a possible complication
following fractures (Kaplan et al., 2004). The risk of developing HO
varies depending on the type of fracture, with incidence of HO reaching
nearly 40% in patients with elbow fractures (Eisenstein et al., 2018;
Foruria et al., 2013, 2014). HO develops around the fracture site, more
typically near a joint, making certain fractures, such as elbow and hip
fractures, more prone to HO formation (Pape et al., 2004). As a result,
most studies have investigated HO in this context and the impact of
fractures occurring away from joints on HO remains less known.
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Clinical manifestations of HO, including soft-tissue loss, joint con-
tractures, motion deficits, stiffness, and chronic pain, can become a
debilitating condition for the affected patients (Vanden Bossche and
Vanderstraeten, 2005). HO has been associated with reduced quality of
life mainly due to extended medical treatment and higher probability of
undergoing additional surgical procedures to remove heterotopic bone
(Winkler et al., 2015). It is therefore not surprising that HO has been
identified as a major obstacle to rehabilitation (Nauth et al., 2012).
HO initially follows similar physiological patterns as the natural
fracture healing process (Nauth et al., 2012). However, HO's patholo-
gical mechanisms are thought to originate from the convergence of
multiple factors including prolonged nervous system and immune
system responses to injury (Forsberg et al., 2014; Convente et al., 2015;
Kraft et al., 2016; Sullivan et al., 2013). More precisely, recent studies
suggest that HO results from exaggerated inflammatory cytokine re-
lease, osteoprogenitor cell proliferation due to inflammation, increased
leptin levels, vascularization of injured tissues, and the activation of
bone morphogenic protein (BMP) signaling, all known to promote bone
formation in extra-skeletal locations (Eisenstein et al., 2018; Nauth
et al., 2012; Firoozabadi et al., 2017).
Traumatic brain injury (TBI) is a known risk factor for the devel-
opment of HO in polytrauma patients (Dizdar et al., 2013; Coelho and
Beraldo, 2009; Ranganathan et al., 2015; Bajwa et al., 2018). Recent
estimates suggest that nearly 20% of patients who suffer from TBI or
spinal cord injuries will develop HO (Cipriano et al., 2009). Moreover,
concomitant limb fracture and TBI is associated with a twofold increase
risk of HO occurrence (Foruria et al., 2014; Dizdar et al., 2013). A
possible explanation for the high occurrence of HO in orthopedic pa-
tients with a TBI is the overlapping physiopathological mechanisms
involved in both injuries, namely dysfunctions in the blood-brain bar-
rier permeability, substance P increase, and prolonged pro-in-
flammatory cytokine release, making the physiological environment
more prone to HO formation (Huang et al., 2018; Evans et al., 2012).
These pathological mechanisms are also observed after the mildest form
of TBI, the mild TBI (mTBI).
MTBIs account for approximately 70–90% of all TBIs sustained and
are frequent among patients who suffered from fractures, with an in-
cidence rate estimated at 23% (Cassidy et al., 2004; Jodoin et al.,
2016). Although considered the mildest form of TBIs, a growing body of
evidence shows that concomitant mTBI can have a significant impact on
recovery in patients with fractures, highlighting the importance of
considering the interaction between these two injuries (Jodoin et al.,
2017a,b). To our knowledge, the association between mTBI and HO has
not been investigated. Lack of medical follow-ups after mTBIs, sub-
clinical HO signs associated with less severe accidents as well as un-
derdiagnosed mTBI in trauma patients presenting with fractures could
partly underlie this lack of scientific interest (Jodoin et al., 2016). Here,
we tested whether isolated limb fracture patients (ILF) presenting with
a concomitant mTBI have a higher incidence rate of HO when com-
pared to ILF patients without a mTBI.
2. Methods
2.1. Participants selection
All participants included in this study were selected from a previous
sample recruited consecutively from a single orthopedic clinic of a
Level 1 Trauma Hospital to evaluate the incidence rate of mTBI among
ILF patients (For more details; Jodoin et al., 2016). Each participant has
consented to grant access to their research data for future studies. This
sample consisted of 251 participants with an ILF of which 58 partici-
pants had suffered from a mTBI based on the American Congress of
Rehabilitation Medicine (ACRM) clinical criteria (loss of consciousness,
loss of memory for the events immediately before or after the accident,
and alteration of mental state at the time of the accident) (Carroll et al.,
2004). A mTBI diagnosis was given when a patient reported at least
three of the four abovementioned criteria. Moreover, patients' medical
files were also screened to gather more information related to the ac-
cident and to the injuries. Patients were eligible to take part in this
study if they had suffered from an ILF and did not meet any of the
exclusion criteria, namely being under 18 years old, substance-related
intoxication at the emergency room, Glasgow Coma Scale under 13 at
emergency admission, health-related complications other than mTBI in
the acute and post-acute injury phases, and non-extremity fractures
(hip, pelvis, ribs, neck, spinal cord, and skull). Moreover, patients were
excluded from the analyses if they presented with signs of HO prior to
the accident and if raters were unable to distinguish between bone
fragment and HO. The study was approved by a local ethics committee.
2.2. Characterization of HO
Participants were included from the initial sample only if radio-
graphs were taken at least 45 days post-trauma. This cut-off was set as
signs of HO can be adequately detected at that time (Cipriano et al.,
2009). Moreover, in cases of multiple radiograph availabilities for a
single patient, the radiograph conducted the closest to three months
post-trauma was selected considering that medical check-ups are fre-
quent at this time and that it falls within the range when HO formation
is typically best detected (Cipriano et al., 2009). Radiographs of all
patients were analyzed separately by a trained senior orthopaedist re-
sident and a senior orthopedic surgeon both blind to the subjects' group
classification. To evaluate signs of HO, both raters used a specialised
radiology display system (NEC Display Solutions; MultiSync Monitor
LCD 2090UXi-20.1; Made in China) to detect the presence of abnormal
bone formation located in extra-skeletal soft tissues. More specifically,
signs of HO were sought for near the fracture location, independently of
joints involvement (see Fig. 1 for a representative case of HO among the
current sample). Hypertrophic callus was excluded from HO cases as
the ossification identified needed to be at the heterotopic site and not at
the fracture callus itself. In addition, Brooker's and Della Valle's clas-
sifications were used conjointly as suggested by Toom et al. (2005)
aiming to improve inter-observer reliability in the assessment of HO.
Inter-rater reliability was verified and reached an almost perfect
agreement according to Cohen's kappa coefficient (k= 0.93). In case of
disagreements among raters, both raters reviewed together the radio-
graph to reach an agreement concerning the presence of HO formation.
2.3. Matched sample procedure
Further steps were taken to control for potential factors known to
affect the risk of HO formation. Patients from the ILF+mTBI group
were matched with ILF patients according to age, sex, type of injury
(area of fracture), and time elapsed between the accident and the
radiograph. The importance of matching for the delay between the
accident and the analyzed radiograph is to control for the risk of HO
signs developing after the analyzed radiograph (Cipriano et al., 2009).
To do so, we proceeded by using a one-on-one matching approach
based on the following criteria: 1) age (± 5 years); 2) sex; 3) type of
injury (area of fracture); 4) time elapsed between the accident and the
radiograph (± 14 days). A match was made when all four criteria
corresponded for two participants from each experimental group
(ILF+mTBI group and ILF group). When more than one participant
from the control group matched with a ILF+mTBI patient based on the
aforementioned criteria, we selected the control participant who cor-
responded most closely to the ILF+mTBI patient. This matching pro-
cess allowed to form 47 near-identical pairs. The remaining participants
who were not matched according to the criteria were excluded from
these analyses.
2.4. Analyses
Descriptive analyses were used to characterize and compare the two
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groups from our study (ILF+mTBI group and ILF group). Results from
descriptive analyses are expressed as means, SD (standard deviation),
and percentages (refer to Tables 1–2). We used Pearson chi-square tests
to compare the incidence rate of HO between the two experimental
groups (ILF+mTBI group and ILF group). Additional chi-square ana-
lyses were conducted to evaluate the possible impact of sex, age group
(18–24; 25–44; 45–64; 65+ years old), joint involvement (periarticular
fracture versus diaphyseal fracture) and surgical procedures on HO
formation. A linear regression analysis was computed to give an esti-
mate on which independent variable, mTBI or joint involvement, best
predicted HO development. Statistical tests were carried out with a α-
level fixed at 0.05. The same pattern of analyses was used to test the
study hypothesis among the matched sample. Moreover, a 2× 2
ANOVA was used to assess the impact of HO and mTBI on return to
work (RTW) among the matched sample. RTW was used in this study to
reflect potential impact of HO development on functional outcome as it
is known to be a good marker of recovery (Clay et al., 2010).
Information on RTW was collected in the context of a previous study
conducted by our group using the same sample (see Jodoin et al.
(2017b) for more details). Statistical analyses were performed using
IBM SPSS software version 24 (Armonk, NY, United States).
3. Results
3.1. Results of full sample analysis
A total of 183 participants were selected, from a study cohort of 251
individuals recruited by our group (see participant flowchart in Fig. 2).
The remaining participants were excluded from the current study due to
the inability to access their radiograph. Among the final sample, 50
patients were in the ILF+mTBI group (females= 19; mean
age= 43.8) and 133 patients were in the ILF group (females= 75;
mean age= 48.9). On average, radiographs were analyzed 86.8 days
post-trauma (range: 45 days–201 days), a delay that was similar be-
tween groups (F=0.01; p=0.92) (see Table 1). There was a sig-
nificantly higher rate of periarticular fractures, as opposed to diaphy-
seal fractures, in the ILF group compared to the ILF+mTBI group
(X2= 16.69; p=0.01) (see Table 2). This difference can be mainly
attributed to the low rate of ILF+mTBI patients with ankle and distal
radius fractures, compared to the ILF patients. Given the higher in-
cidence of mTBI in fractures occurring proximally to the head (Jodoin
et al., 2016), risks of suffering from a mTBI are rare in individuals
treated for ankle and distal radius fractures.
Patients in the ILF+mTBI group showed significantly more signs of
HO compared to patients with an ILF alone (X=6.50; p=0.01), with
the majority of patients presenting with low grade HO according to
Brooker's and Della's Valle's classification (see Tables 3–4). The in-
cidence rates of HO signs were 46.0% in ILF+mTBI patients (23/50)
as opposed to 26.3% in patients with an ILF alone (35/133). Of note,
sex (X2= 2.32; p=0.10), age group (X2=2.08; p=0.56), and sur-
gical procedures (X2= 1.71; p=0.13) were unrelated to the detection
of signs of HO. Furthermore, rates of HO signs were found to be similar
whether the fracture occurred proximally (periarticular fracture) or
distally (diaphyseal fracture) to a joint (X2= 1.68; p=0.24). See
Table 5 for more details. Lastly, results from the computed linear re-
gression analysis show that sustaining a concomitant mTBI significantly
predicted risks of HO development (β-coefficient= 0.18; t=2.29;
p=0.02), whereas joint involvement was unrelated to HO develop-
ment (β-coefficient=−0.05; t=−0.56; p=0.58).
Fig. 1. Representative case of HO among sample.
Table 1
Descriptive characteristics of full study cohort by group.
Total mTBI No TBI P-value
N (subjects) 183 50 133 –







Sex (Female [%]) 94 (51.4) 19 (38.0) 75 (56.4) 0.02*
Surgical procedures (% of sample) 32.7 26.8 34.6 0.23
Delay between trauma and
analyzed radiograph (days)
86.8 87.2 86.7 0.92
*=Level of significance was set at p< 0.05
Table 2
Distribution of fracture characteristics.
Body distribution of fractures [Number of patients] Total mTBI No TBI
- Metacarpal 2 1 1
- Metatarsal 11 3 8
- Proximal humerus 21 7 14
- Humerus diaphysis 5 1 4
- Distal humerus 6 0 6
- Scapula 3 2 1
- Clavicle 18 11 7
- Proximal ulna 5 2 3
- Ulna diaphyseal 3 2 1
- Distal radius 45 8 37
- Femur 2 1 1
- Patella 2 1 1
- Proximal tibia 4 2 2
- Diaphyseal tibia 7 3 4
- Distal tibia 9 2 7
- Ankle 40 4 36
Joint involvement Total mTBI No TBI P-value
- Yes (periarticular fracture) 146 30 116 0.01
- No (diaphyseal fracture) 37 20 17
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3.2. Results of analyses from the matched sample
A total of 94 participants were matched (i.e.; 47 patients from the
ILF+mTBI group and 47 patients from the ILF group). Participants
from both groups were equivalent according to the following criteria:
age (t=0.00; p=1.00), sex (X2= 0.00; p=1.00), area of injury
(X2= 0.00; p= 1.00), and delay between the accident and the ana-
lyzed radiograph (t=1.08; p=0.30). Groups did not differ based on
rates of surgical procedures (X2= 1.73; p=0.25). Refer to Table 6 to
obtain detailed descriptive characteristics regarding the matched
sample.
Similar to results obtained with the full sample, HO incidence was
significantly higher in ILF+mTBI patients in comparison to ILF pa-
tients (X2= 3.69; p=0.04) (see Table 7). This result further supports
the notion that concomitant mTBI puts ILF patients at greater risk of
developing HO. More specifically, 46.8% of ILF+mTBI patients (22/
47) from the matched sample presented signs of HO compared to only
27.7% in ILF patients without a mTBI (13/47). Presence of HO nega-
tively impacted RTW delays in patients with ILF+mTBI (F=4.055;
251 participants 
1) 58 ILF+mTBI patients 
2) 193 ILF patients 
Initial sample 
183 participants 
3) 50 ILF+mTBI patients 
4) 133 ILF patients 
Patients excluded due to inability 
to access follow-up radiographs 
or because follow-ups ended 
within 45 days post-trauma 
1) 8 ILF+mTBI patients 
2) 60 ILF patients  
Full sample 
First round of analyses  
1) Age 
2) Sex 
3) Type of injury 
4) Delay between accident and analyzed 
radiograph 
94 participants 
1) 47 ILF+mTBI patients 
2) 47 ILF patients 
Patients excluded following the 
matching process 
1) 3 ILF+mTBI patients 
2) 86 ILF patients  
Matching process 
Matched sample 
Second round of analyses 
Fig. 2. Participant selection flowchart.
Table 3
HO signs among full sample.
mTBI No TBI X2 P-Value







*=Level of significance was set at p< 0.05
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p=0.05). Return to work delays did not statistically differ according to
the presence of HO in ILF patients without a comorbid mTBI
(F= 0.823; p=0.37). More specifically, ILF+mTBI patients with HO
took, on average, 379 days to RTW compared to 106 days for ILF pa-
tients with HO but without a mTBI. As for ILF+mTBI patients without
HO, it took, on average, 214 days to RTW as opposed to 168 days for ILF
patients without HO and mTBI.
4. Discussion
This study investigated the incidence rate of HO among ILF patients
with or without a concomitant mTBI. Results from the present study
suggest that presence of HO is significantly higher in patients with both
trauma injuries (mTBI and ILF) compared to ILF patients, even after
controlling for factors known to influence HO, such as age, sex, area of
injury, and time elapsed between the accident and the analyzed
radiograph. Moreover, results from linear regressions show that sus-
taining a concomitant mTBI significantly predicts risks for HO devel-
opment whereas suffering from a fracture near a joint was unrelated.
These findings are of particular interest, considering the high pre-
valence of both injuries, namely ILF and mTBI, and the possible dele-
terious consequences of HO on recovery and quality of life. In addition,
the clinical symptoms linked to HO combined with possible additional
surgical procedures to remove the heterotopic bone represent stag-
gering financial burdens (health care expenditures and loss of pro-
ductivity) (Eisenstein et al., 2018).
Another striking finding from this study is that the combination of
HO formation and mTBI was associated with significantly longer RTW
delays after an isolated limb fracture. Of note, mTBI without HO also
negatively impacted RTW in ILF patients, but to a lesser extent than in
the presence of HO. Indeed, results show a near 45% increase in delays
to RTW when HO signs were detected in ILF+mTBI patients compared
to ILF+mTBI patients without HO. This is particularly alarming con-
sidering that almost half of the assessed patients with an ILF and a
comorbid mTBI presented signs of HO. This finding points to the clin-
ical relevance of systematically implementing a follow-up visit at least
with ILF+mTBI patients if we are to investigate the impact of mTBI on
clinical outcomes associated with HO such as pain, stiffness, and ar-
ticular amplitude.
Most studies interested in the impact of concomitant TBI on the risk
for HO formation focused on polytrauma patients or severely injured
patients who suffered from a moderate to severe TBI and mostly focused
on HO occurring near a joint (Bajwa et al., 2018; Garland, 1991a,b;
Boes et al., 2006). The present study, however, shows that patients with
an injury considered less severe, such as an ILF, are significantly more
vulnerable to HO formation, regardless of joint involvement, when also
afflicted by a comorbid mTBI. To the best of our knowledge, this is the
first study specifically investigating the impact of mTBI on HO forma-
tion among an orthopedic population. The fact that mTBI typically re-
ceives limited medical attention beyond the acute post-accident phase
can serve as a possible explanation. Another possibility could be that
mTBI patients is not a clinical condition that justifies exposing unin-
jured bones to X-ray radiation, thus preventing the detection of HO
formation in mTBI-alone patients.
From a clinical standpoint, these results shed light on the im-
portance of accounting for the presence of mTBI when treating ILF
patients considering that over 44% of patients presenting with both
injuries will develop HO. HO presence is classically studied in a context
of hip and elbow secondary ankylosis and severe neurological con-
comitant injury. Although conjectural, this study provides preliminary
evidence of the significant impact of mild HO on patient outcome and
extends HO screening beyond joints. Importantly, the addition of dia-
physeal HO screening provides new information on whole-bone in-
cidence rates of HO following a single fracture. Multiple factors may be
at stake with regard to the higher incidence of HO among ILF+mTBI
patients. For example, HO is believed to originate from the convergence
of multiple mechanisms that closely involve the interaction of the
Table 4
Identification of HO according to Brooker's and Della Valle's classifications.
Total mTBI No TBI





Isolated ossifications less than 1 cm in length
46 20 26
- B1
Isolated ossifications at least 1 cm in length – leaving
MORE than 1 cm distance between pelvis and femur
2 2 0
- B2
Marginal ossifications – leaving MORE than 1 cm
distance between pelvis and femur
3 0 3
- C1
Isolated ossifications at least 1 cm in length – leaving




Marginal ossifications – leaving LESS than 1 cm distance
between pelvis and femur or ankylosis
4 2 2
- C3
Ankylosis – leaving LESS than 1 cm distance between
pelvis and femur or ankylosis
1 0 1
Table 5
Risks of HO in relation to joint involvement.
Periarticular fracture Diaphyseal fracture P-value
mTBI
- Number of subjects with HO [%] 14/30 (46.7) 9/20 (45.0) 0.57
No mTBI
- Number of subjects with HO [%] 29/116 (25.0) 6/17 (35.3) 0.38
P-value 0.02* 0.40
*=Level of significance was set at p<0.05
Table 6
Descriptive characteristics of matched sample by group.
Total mTBI No TBI P-value
N (subjects) 94 47 47 –







Sex (Female [%]) 34 (36.2) 17 (36.2) 17 (36.2) 1.00
Surgical procedures (% of sample) 33.7 26.3 40.0 0.25
Delay between trauma and
analyzed radiograph (days)
92.4 98.8 86.1 0.30
Table 7
HO signs among matched sample.
mTBI No TBI X2 P-Value







*=Level of significance was set at p<0.05
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immune system and the central nervous system (Forsberg et al., 2014;
Convente et al., 2015; Kraft et al., 2016; Sullivan et al., 2013). More
specifically, a growing body of evidence highlights the involvement of
the blood-brain-barrier (BBB) in HO formation (Huang et al., 2018).
Interestingly, BBB permeability dysfunction is a well-known con-
sequence of TBI and has been identified as a cause for high incidence
rates of HO in patients with moderate to severe TBIs (Toffoli et al.,
2008). Recent studies have shown that mTBI also leads to BBB dys-
function which can act as a facilitator in the central nervous system
invasion of peripheral immune response substances, such as in-
flammatory cytokines, following a peripheral insult (Rowe et al., 2016).
Additionally, neuroendocrine regulation, a system that is often deficient
following mTBI, is closely involved in bone remodeling and HO for-
mation (Undurti et al., 2018). Although speculative, it may be possible
that the physiopathology of bone fracture and that of mTBI synergis-
tically interact to promote HO formation. Shedding light on the possible
involvement of physiopathological underpinnings of mTBI in HO could
help identify new treatment targets and clinical management strategies
aiming to minimize HO formation. In this study, HO was most fre-
quently classified as low grade with small bone formation. This level of
HO most likely does not cause decreased function by itself. We hy-
pothesize that this low-grade HO is a sign of increased local soft tissue
injury and increased neurological inflammation that is secondarily af-
fecting outcome.
One limitation to the current study is that it uses data from parti-
cipants recruited in the context of a previous study, which potentially
restricts study findings generalization. Secondly, collection of pro-
spective data should systematically control for the time elapsed since
the injury at the time of radiographs (for example, all taken at three
months post-accident) so as to reduce risks for missed HO diagnoses.
One interesting avenue in further investigating the relation between
RTW delays and HO formation would be to specify the type of work
conducted (light versus heavy work) as well as the quality of the RTW
(successful RTW versus work accommodations needed). Moreover, in-
vestigating RTW delays in relation with both prospective functional
recovery measures and low-grade HO could help us identify therapeutic
targets for optimal orthopedic trauma recovery. Given that some frac-
tures are more prone to HO formation, larger-scale replication studies
should consider data stratification analyses according to injury types.
Gained knowledge would allow us to further refine classification of at-
risk patients. Finally, future studies should account for additional fac-
tors, such as injury severity, duration of immobilization, and pre-injury
conditions, such as, but not limited to, history of HO and genetic pre-
disposition, as they are known to impact HO formation (Pape et al.,
2004; Dizdar et al., 2013).
5. Conclusion
In conclusion, study findings highlight that sustaining a comorbid
mTBI puts ILF patients at significantly higher risk of developing HO.
Moreover, ILF patients with a mTBI are greatly impacted by HO in
relation with RTW, a factor associated with high productivity costs and
risks for chronic fracture injury symptoms. This is of significant clinical
interest considering the high incidence of both injuries, the frequency at
which mTBI goes undiagnosed, and the clinical impact of HO on re-
covery. The impact of mTBI on HO formation warrants further attention
to detect early signs of HO, to identify shared physiopathological me-
chanisms and, ultimately, to design targeted therapies.
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